64 filings
Page 2 of 4
8-K
0kcc3i5e
25 Mar 22
Departure of Directors or Certain Officers
5:23pm
8-K
b24i3ga1nm87 8b68qp
15 Feb 22
ImmunityBio Completes Acquisition of Athenex’s Interest in Dunkirk, New York Advanced
9:00am
8-K
ycv1vc4cj42p
12 Jan 22
Entry into a Material Definitive Agreement
8:35am
8-K
enqcn
20 Dec 21
Immunitybio Announces Completion of $470 Million Post-merger Financing to Fund Late-stage Cancer Clinical Trials, Phase 3 of Covid
9:07am
8-K
xq1kok2afl6w3 ro
27 Sep 21
Entry into a Material Definitive Agreement
8:46am
8-K
edk43b6r
13 Sep 21
Results of Operations and Financial Condition
8:37am
8-K
g60bexcsef 32g2
13 Aug 21
Departure of Directors or Certain Officers
4:16pm
8-K
lnkwb 13myl1
15 Jun 21
Submission of Matters to a Vote of Security Holders
7:11am
8-K
ncg pc6mimi
11 Jun 21
Results of Operations and Financial Condition
5:18pm
8-K
ymhad 2dku67jr
4 Jun 21
Regulation FD Disclosure
8:30am
8-K
3ayyvmqbsa w8n
28 May 21
Entry into a Material Definitive Agreement
4:08pm
8-K
67dkr 1nus
3 May 21
Entry into a Material Definitive Agreement
6:06am
8-K/A
c5lhp5kt4zm94ym8
22 Apr 21
Index to Immunitybio Consolidated Financial Statements
4:06pm
8-K
oa95acu3d2t7pr
1 Apr 21
ImmunityBio Appoints Dr. Linda Maxwell and CEO Richard Adcock to Board of Directors
9:15am
8-K
sr98 49dmsyc5
17 Mar 21
Regulation FD Disclosure
5:24pm
8-K
m4jf3jg
9 Mar 21
ImmunityBio and NantKwest Complete Merger
9:58pm
8-K
9ew4p
25 Feb 21
Other Events
5:15pm
8-K
vlfl1hrktz8ljeot
24 Feb 21
ImmunityBio Appoints John Brennan and Wesley Clark to Board of Directors
4:59pm
8-K
0mcf48u7ubyoq2sivc
10 Feb 21
Departure of Directors or Certain Officers
4:38pm
8-K
yt8e7
13 Jan 21
Regulation FD Disclosure
9:17am